Cargando…
Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis
PURPOSE: We conducted a systematic review to investigate the effectiveness of clinical treatments for wet age-related macular degeneration (wAMD) in Japanese patients in the decade since anti-vascular endothelial growth factor (VEGF) therapies were introduced. METHODS: PubMed was searched for articl...
Autores principales: | Takahashi, Kanji, Iida, Tomohiro, Ishida, Susumu, Crawford, Bruce, Sakai, Yoko, Mochizuki, Akikazu, Tsujiuchi, Ryuta, Tanaka, Satoru, Imai, Kota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888332/ https://www.ncbi.nlm.nih.gov/pubmed/35250261 http://dx.doi.org/10.2147/OPTH.S345403 |
Ejemplares similares
-
Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
por: Iida, Tomohiro, et al.
Publicado: (2016) -
Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
por: Yanagi, Yasuo, et al.
Publicado: (2023) -
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan
por: Mukai, Ryo, et al.
Publicado: (2023) -
Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan
por: Yanagi, Yasuo, et al.
Publicado: (2023) -
Impact of neovascular age-related macular degeneration: burden of patients receiving therapies in Japan
por: Honda, Shigeru, et al.
Publicado: (2021)